MyoKardia, Inc. (Nasdaq: MYOK) announced that it has commenced a proposed underwritten public offering to sell $200,000,000 in shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE